US Digital Pathology 2022
29 September 22
| Eder Lagemann and Sidney Tate
Digital pathology for primary diagnosis is nascent in the US, but it is primed for rapid growth, similar to what is currently being seen in Europe (see KLAS’ report on global digital pathology ). In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction. 33 of the interviewed organizations are live with digital pathology; the rest are currently implementing or making plans for the future.
Latest Comments See all (20) comments Filtered view: ##.#% ##.#% ##.#% Download as Excel
Director
Value
A lot of the savings that Trulla shows us look like savings on paper,...
Director
Product, Value
One of my biggest beefs with the solution is that, in theory, Trulla...
Director
Product
Trulla is basically an inventory management system. I don't think...
Director
Relationship, Operations
Overall, the implementation was good. The support that SpendMend...
Director
Relationship
SpendMend has been really good about hearing our needs and...
Director
Value
I am fully confident that what the vendor is reporting is accurate...
Director
Loyalty, Relationship
Because of when we went with Trulla and the size of our organization,...
Director
Value
SpendMend’s business model and fee structure are more than fair. There...
Director
Product
Trulla’s design is simple. It shows us what we need to know. It is...
Director
Relationship
Trulla meets our needs. SpendMend is always thinking about where to go...